Your browser is no longer supported. Please, upgrade your browser.
Settings
OPK OPKO Health, Inc. daily Stock Chart
OPK [NASD]
OPKO Health, Inc.
Index- P/E- EPS (ttm)-0.27 Insider Own5.40% Shs Outstand618.17M Perf Week-5.67%
Market Cap1.44B Forward P/E- EPS next Y-0.12 Insider Trans4.81% Shs Float357.10M Perf Month-7.54%
Income-153.00M PEG- EPS next Q-0.09 Inst Own23.30% Short Float23.80% Perf Quarter-35.81%
Sales990.30M P/S1.45 EPS this Y50.20% Inst Trans-1.02% Short Ratio15.94 Perf Half Y-35.10%
Book/sh3.12 P/B0.75 EPS next Y60.00% ROA-6.10% Target Price5.33 Perf Year-25.08%
Cash/sh0.16 P/C14.93 EPS next 5Y12.00% ROE-8.50% 52W Range2.29 - 6.40 Perf YTD-22.59%
Dividend- P/FCF- EPS past 5Y3.40% ROI-6.60% 52W High-63.59% Beta1.86
Dividend %- Quick Ratio1.00 Sales past 5Y59.30% Gross Margin38.90% 52W Low1.75% ATR0.10
Employees5690 Current Ratio1.10 Sales Q/Q37.80% Oper. Margin-17.30% RSI (14)38.03 Volatility4.53% 3.72%
OptionableYes Debt/Eq0.12 EPS Q/Q66.00% Profit Margin-15.50% Rel Volume0.76 Prev Close2.41
ShortableYes LT Debt/Eq0.10 EarningsMay 29 AMC Payout- Avg Volume5.33M Price2.33
Recom1.30 SMA20-6.74% SMA50-10.08% SMA200-38.36% Volume4,034,804 Change-3.32%
Mar-02-18Downgrade JP Morgan Neutral → Underweight
Sep-14-17Downgrade JP Morgan Overweight → Neutral
Jun-21-16Reiterated Standpoint Research Buy $16 → $18
Jun-03-16Initiated Standpoint Research Buy $16
Mar-31-16Reiterated Barrington Research Outperform $17 → $16
Oct-16-15Initiated JP Morgan Overweight $14
Sep-11-15Downgrade Jefferies Buy → Hold
Mar-03-15Downgrade Oppenheimer Outperform → Perform
May-12-14Reiterated Oppenheimer Outperform $13 → $12
Mar-14-14Initiated Oppenheimer Outperform $13
Nov-13-13Reiterated Ladenburg Thalmann Buy $10 → $14.50
May-30-13Reiterated Ladenburg Thalmann Buy $8.50 → $10
Oct-22-12Initiated Barrington Research Outperform $6
Dec-01-11Reiterated Ladenburg Thalmann Buy $6 → $8.50
Jul-14-11Initiated Ladenburg Thalmann Buy $6
Apr-22-19 01:28PM  Weekly CEO Buys Highlight GuruFocus.com
Apr-20-19 10:36PM  Stocks That Fell to 3-Year Lows in the Week of April 19 GuruFocus.com
Apr-17-19 11:32AM  BioReference Laboratories Recognized by Forbes as Best Large Employer of 2019 GlobeNewswire
Apr-15-19 06:46PM  Weekly CEO Buys Highlight GuruFocus.com
Apr-14-19 12:11PM  Weekly Top Insider Buys Highlight for the Week of April 12 GuruFocus.com
Apr-12-19 08:00AM  OPKO Reports Additional Oxyntomodulin, OPK-88003, Results From Phase 2 Diabetes and Obesity Trial GlobeNewswire
Apr-07-19 10:45PM  Weekly CEO Buys Highlight GuruFocus.com
Apr-01-19 10:51AM  Read This Before Selling OPKO Health, Inc. (NASDAQ:OPK) Shares Simply Wall St.
Mar-21-19 08:00AM  OPKO Announces Positive Topline Results In Phase 2 Diabetes And Obesity Trial GlobeNewswire +10.57%
Mar-06-19 12:15PM  Edited Transcript of OPK earnings conference call or presentation 27-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Mar-04-19 09:10AM  OPKO Health (OPK) Reports Loss in Q4, Misses on Revenues Zacks
Mar-01-19 09:48PM  OPKO Health Inc (OPK) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com +7.45%
Feb-28-19 03:49PM  Who OPKO Health Is Tanking Today Motley Fool -8.27%
10:00AM  Watch These Four Healthcare Stocks Set The Pace on Thursday ACCESSWIRE
Feb-27-19 11:51PM  Opko Health Inc (OPK) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:05PM  OPKO Health Reports 2018 Fourth Quarter Business Highlights and Financial Results GlobeNewswire
Feb-26-19 08:00AM  OPKO Health to Announce Fourth Quarter 2018 Financial Results on February 27, 2019 GlobeNewswire
Feb-13-19 08:30AM  Research Report Identifies Cognizant Technology Solutions, OPKO Health, MedEquities Realty Trust, AXT, Red Robin Gourmet Burgers, and Dorian LPG with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Feb-05-19 04:33PM  Why Glu Mobile, Opko Health, and Church & Dwight Slumped Today Motley Fool -15.63%
12:07PM  Why Opko Health Is Tanking Today Motley Fool
08:30AM  OPKO Health, Inc. Announces the Pricing of its Offering of Convertible Senior Notes GlobeNewswire
07:47AM  The Daily Biotech Pulse: Gilead Earnings, Codexis Sings Pact With Merck, Eli Lilly Reports Positive Trial Results Benzinga
12:30AM  Johnson Fistel, LLP Announces Investigations of AbbVie Inc., Macquarie Infrastructure Corporation, OPKO Health, Inc. and Uxin Limited; Investors Encouraged to Contact Firm PR Newswire
Feb-04-19 04:20PM  OPKO Health, Inc. Announces Proposed Offering of Convertible Senior Notes GlobeNewswire
Feb-01-19 02:15PM  Opko gets FDA OK for fingerstick test, seeks reversal on non-coverage ruling American City Business Journals
08:00AM  OPKO Health Receives FDA Approval for the Point-of-Care Sangia PSA Test with the Claros® 1 Analyzer GlobeNewswire
Jan-31-19 09:15PM  OPKO Provides Update on the Development of OPK-88004, a Selective Androgen Receptor Modulator GlobeNewswire
08:00PM  Future Non-Coverage Determination for 4Kscore Test Posted by Novitas GlobeNewswire
Jan-28-19 08:00AM  Today's Research Reports on Trending Tickers: OPKO Health and Endo International ACCESSWIRE -8.92%
07:30AM  BioReference Laboratories Supports Federal Employees Amidst Government Shutdown GlobeNewswire
Jan-22-19 09:10AM  Here's Why Investors Should Bet on Abiomed (ABMD) Stock Now Zacks
08:14AM  Varian Medical's (VAR) ProBeam Compact Picked by Biopolis Zacks
Jan-21-19 02:55PM  Weekly CEO Buys Highlight GuruFocus.com
Jan-18-19 04:13PM  Insiders Roundup: Stryker Corp, OPKO Health GuruFocus.com
07:53AM  Cerner Picked by Remi Vista for Behavioral Health Technology Zacks
Jan-17-19 09:30AM  Here's Why Investors Should Retain athenahealth (ATHN) Stock Zacks
08:41AM  Allscripts Selected by Premier for Connected Health Platform Zacks
Jan-16-19 08:44AM  Here's Why You Should Invest in OPKO Health (OPK) Right Now Zacks
Jan-15-19 10:24AM  Here's Why Investors Should Hold Patterson Companies Stock Zacks
Jan-14-19 02:56PM  Judge approves settlements for billionaire Frost, Opko Health in SEC lawsuit American City Business Journals
09:32AM  Here's Why Investors Should Hold McKesson (MCK) Stock Now Zacks
09:15AM  4 Healthcare Stocks Setting The Pace On Monday (1/14/19) ACCESSWIRE
07:14AM  Cerner & Christiana Care Unite to Offer Bariatric Services Zacks
Jan-13-19 11:14AM  Weekly CEO Buys Highlight GuruFocus.com
Jan-11-19 09:20AM  Here's Why You Should Invest in Surmodics (SRDX) Stock Now Zacks
Jan-10-19 09:08AM  Here's Why You Should Invest in Veeva Systems (VEEV) Now Zacks
08:31AM  Masimo's (MASI) Preliminary Results for 2018 Cheer Investors Zacks
05:57AM  Intuitive Surgical (ISRG) Up on Solid Preliminary Q4 Results Zacks
Jan-09-19 10:22AM  Barrington Research: With SEC Litigation Settled, Opko Health Should Outperform Benzinga
09:37AM  Allscripts (MDRX) Collaborates With Microsoft, Shares Up Zacks
06:55AM  Luminex's (LMNX) Preliminary Q4 Results Cheer Investors Zacks
06:44AM  Here's Why You Should Hold Varian Medical (VAR) Stock Now Zacks
Jan-08-19 08:41AM  Abiomed's (ABMD) Preliminary Q3 Results Cheer Investors Zacks
Jan-07-19 12:45PM  Weekly CEO Buys Highlight GuruFocus.com
12:21PM  Opko Health appoints executive chairman for BioReference Laboratories American City Business Journals
10:03AM  Here's Why Investors Should Hold Luminex (LMNX) Stock Now Zacks
08:08AM  Insider Buys Of The Week: FedEx, TechnipFMC, Opko Health Benzinga
06:00AM  OPKO Health Appoints Jon R. Cohen, M.D. Executive Chairman of BioReference Laboratories GlobeNewswire
Jan-03-19 09:10AM  Luminex Buys MilliporeSigma's Flow Cytometry Unit for $75M Zacks
09:04AM  Here's Why You Should Invest in PerkinElmer (PKI) Stock Now Zacks
Jan-02-19 07:18AM  Here's Why You Should Invest in Wright Medical (WMGI) Now Zacks +9.30%
Dec-31-18 07:30AM  Biotech Companies in the News ACCESSWIRE
Dec-30-18 09:09AM  Opko Surge Boosts Israeli Shares on Otherwise Calm Day: Inside EM Bloomberg
Dec-29-18 03:29PM  Miami billionaire, museum donor settles fraud complaint Associated Press
Dec-28-18 04:32PM  Why Aphria, Weatherford International, and Opko Health Jumped Today Motley Fool +24.90%
12:21PM  Biotech billionaire Philip Frost agrees to proposed judgment in SEC case CNBC
12:00PM  Dow Subdued on the Last Friday of the Year Barrons.com
09:20AM  4 Healthcare Stocks Gaining Speed on Friday (12/28/18) ACCESSWIRE
09:06AM  Ecolab Inks Deal With Clearway for Renewable Power Project Zacks
09:00AM  Here's Why Investors Should Retain CONMED (CNMD) Stock Now Zacks
08:24AM  Becton, Dickinson's MAX Enteric Viral Panel Cleared by FDA Zacks
08:20AM  Here's Why You Should Buy Intuitive Surgical (ISRG) Now Zacks
07:39AM  Billionaire Phillip Frost, Opko agree to settle SEC lawsuit American City Business Journals
07:29AM  The Daily Biotech Pulse: Opko Settles With SEC, Obalon Inks Financing Deals, Harpoon Files For IPO Benzinga
Dec-27-18 05:53PM  Florida biotech billionaire settles SEC stock manipulation case Reuters
04:34PM  OPKO Health and OPKO's CEO and Chairman, Dr. Phillip Frost, Announce Proposed Resolution of SEC Action PR Newswire
Dec-26-18 09:41AM  Varian Medical's (VAR) Halcyon Excluded From Trade Tariffs Zacks
08:22AM  Here's Why You Should Hold Becton, Dickinson (BDX) Stock Now Zacks
Dec-24-18 09:22AM  Integra Rides on Global Prospects, Hurt by Escalating Costs Zacks
08:14AM  Quest Diagnostics (DGX) Divests India Business to Strand Zacks
Dec-22-18 04:07AM  Is Opko Health Inc. (OPK) Going to Burn These Hedge Funds? Insider Monkey
Dec-21-18 03:00PM  SEC in settlement discussions in Frost, Opko case American City Business Journals -5.54%
09:27AM  Cala Health Picks Medidata Cloud for Observational Study Zacks
Dec-20-18 08:40AM  Inogen Gains From Commercial Launch of Wireless Connect Zacks
Dec-19-18 08:47AM  Here's Why You Should Hold HealthEquity (HQY) Stock for Now Zacks -5.32%
Dec-18-18 02:59PM  SEC to amend lawsuit against billionaire Frost, Opko American City Business Journals -5.05%
08:39AM  Here's Why You Should Hold Cooper Companies (COO) Stock Now Zacks
Dec-14-18 08:13AM  CONMED's Buffalo Filter Buyout Likely to be Accretive in 2020 Zacks
Dec-13-18 09:06AM  Varian Medical's Eclipse Picked by Paul Scherrer Institute Zacks
09:04AM  Here's Why You Should Hold Baxter International (BAX) Now Zacks
Dec-11-18 08:46AM  Varian Medical ProBeam-Equipped Emory Center Opens in Georgia Zacks
Dec-10-18 08:45AM  Baxter & EFCNI Collaborate to Improve Care for Preterm Born Zacks
08:44AM  Here's Why You Should Invest in athenahealth (ATHN) Now Zacks
Dec-03-18 07:00AM  Today's Research Reports on Trending Tickers: AbbVie and OPKO Health ACCESSWIRE
Nov-30-18 08:32AM  Here's Why You Should Invest in Surmodics (SRDX) Right Now Zacks
Nov-19-18 11:50AM  Biotech and Cannabis Companies To Watch ACCESSWIRE
05:00AM  Edited Transcript of OPK earnings conference call or presentation 9-Nov-18 9:15pm GMT Thomson Reuters StreetEvents
Nov-13-18 09:40AM  FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against OPKO Health, Inc. (OPK) & Lead Plaintiff Deadline: November 13, 2018 ACCESSWIRE -6.31%
09:12AM  OPKO Health (OPK) Incurs Loss in Q3, Lags Revenue Estimates Zacks
06:51AM  Todays Research Reports on Stocks to Watch: OPKO Health and Exact Sciences ACCESSWIRE
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories, a clinical laboratory that offers laboratory testing services. The Bio-Reference Laboratories also provides core genetic testing and leverage products, such as the 4Kscore prostate cancer test and the Claros 1 in-office immunoassay platform. The company's Pharmaceutical segment offers Rayaldee, a treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, a selective androgen receptor modulator for benign prostatic hyperplasia, and other urologic and metabolic conditions; and OPK88003, a once or twice weekly oxyntomodulin that is in Phase II trials for type 2 diabetes and obesity. It is also developing hGH-CTP, a once-weekly human growth hormone injection in Phase III clinical trial in partnership with Pfizer, Inc.; VARUBI for chemotherapy-induced nausea and vomiting; and Factor VIIa drug for hemophilia. In addition, this segment develops and produces specialty active pharmaceutical ingredients; and discovers drugs for the treatment of cancer, heart disease, metabolic disorders, and a range of genetic anomalies. Further, it develops, manufactures, markets, and sells pharmaceutical, nutraceutical, and veterinary products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro- intestinal products, hormones, and others. Additionally, the company operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FROST PHILLIP MD ET ALCEO & ChairmanApr 22Buy2.3280,000185,61325,885,177Apr 23 06:13 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 17Buy2.4250,000120,95325,805,177Apr 18 07:17 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 16Buy2.5010,00024,99725,755,177Apr 17 07:09 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 15Buy2.4710,00024,65025,745,177Apr 16 06:56 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 12Buy2.5020,00049,99425,735,177Apr 15 06:09 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 11Buy2.4930,00074,56125,715,177Apr 12 06:02 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 10Buy2.5320,00050,60225,685,177Apr 11 07:13 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 09Buy2.5110,00025,09325,665,177Apr 10 06:10 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 04Buy2.5320,00050,62725,655,177Apr 05 07:20 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 02Buy2.5340,000101,18725,635,177Apr 03 06:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 01Buy2.5820,00051,56025,595,177Apr 02 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 27Buy2.49100,000248,64625,575,177Mar 28 07:19 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 18Buy2.4740,00098,98325,475,177Mar 19 06:52 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 14Buy2.45250,000612,91825,435,177Mar 15 09:23 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 06Buy2.5750,000128,62225,185,177Mar 07 09:45 AM
Rubin Steven DExecutive VP-AdministrationMar 06Buy2.568,00020,4525,719,147Mar 07 09:45 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 28Buy2.48200,000495,94725,135,177Mar 01 07:38 AM
Rubin Steven DExecutive VP-AdministrationFeb 01Option Exercise0.6624,87716,4195,716,792Feb 05 04:33 PM
FROST PHILLIP MD ET ALCEO & ChairmanJan 17Buy3.6715,00055,03124,935,177Jan 18 06:55 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 16Buy3.7410,00037,36924,920,177Jan 17 06:52 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 14Buy3.7415,00056,05524,910,177Jan 15 06:16 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 11Buy3.8310,00038,32524,895,177Jan 14 06:51 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 10Buy3.6910,00036,90824,885,177Jan 11 06:59 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 09Buy3.6510,00036,50124,875,177Jan 10 07:11 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 08Buy3.6135,000126,37624,865,177Jan 09 07:11 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 07Buy3.5655,000195,92224,830,177Jan 08 07:32 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 04Buy3.4330,000102,91424,775,177Jan 07 07:11 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 03Buy3.2550,000162,69324,745,177Jan 04 06:55 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 02Buy3.2440,000129,71324,695,177Jan 03 07:51 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 31Buy2.97135,000401,06824,655,177Jan 02 08:44 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 28Buy3.13100,000312,89824,520,177Dec 31 07:07 AM
Fishel Robert ScottDirectorSep 07Buy4.6310,00046,3004,070,728Sep 10 06:30 AM
FROST PHILLIP MD ET ALCEO & ChairmanSep 07Buy5.5710,00055,7054,362,870Sep 10 06:30 AM
FROST PHILLIP MD ET ALCEO & ChairmanSep 05Buy5.7910,00057,9434,352,870Sep 06 07:40 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 30Buy5.905,00029,4754,342,870Aug 31 06:24 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 28Buy5.805,00028,9944,337,870Aug 29 06:02 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 24Buy5.7015,00085,5534,332,870Aug 27 07:25 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 17Buy5.5410,00055,3584,317,870Aug 20 07:07 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 13Buy5.3315,00079,9324,307,870Aug 14 06:10 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 09Buy5.4510,00054,5254,292,870Aug 10 07:10 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 26Buy5.0690,000455,2064,282,870Jul 27 06:30 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 25Buy5.4760,000328,2484,192,870Jul 26 06:28 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 24Buy5.6055,000307,7694,132,870Jul 25 06:52 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 20Buy5.8910,00058,9004,077,870Jul 23 06:39 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 19Buy5.9510,00059,5004,067,870Jul 20 06:22 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 18Buy6.0510,00060,5004,057,870Jul 19 06:44 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 16Buy5.6815,00085,2494,047,870Jul 17 07:17 AM
Fishel Robert ScottDirectorJul 11Buy6.002,50014,9914,060,728Jul 12 07:12 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 03Buy4.7510,00047,5014,032,870Jul 05 07:35 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 29Buy4.717,72036,3354,022,870Jul 02 06:23 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 28Buy4.6820,00093,6004,015,150Jun 29 07:09 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 27Buy4.7510,00047,5003,995,150Jun 28 06:54 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 22Buy4.4510,00044,5003,985,150Jun 25 06:47 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 21Buy4.5430,000136,2003,975,150Jun 22 06:41 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 19Buy4.3220,00086,3003,945,150Jun 20 06:19 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 18Buy4.3414,29962,0133,925,150Jun 19 06:25 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 15Buy4.4210,00044,2003,910,851Jun 18 06:10 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 11Buy4.2210,00042,2003,900,851Jun 12 06:17 AM
Logal AdamSr. Vice President, CFOJun 08Option Exercise3.4375,000257,250239,858Jun 12 06:05 PM
FROST PHILLIP MD ET ALCEO & ChairmanJun 07Buy4.0410,00040,4003,890,851Jun 08 07:37 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 06Buy4.0530,000121,5003,880,851Jun 07 07:11 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 31Buy3.763,90014,6643,850,851Jun 01 06:49 AM
Fishel Robert ScottDirectorMay 29Buy3.732,5009,3334,058,228May 30 07:29 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 25Buy3.7010,00037,0003,846,951May 29 06:31 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 23Buy3.7340,000149,3003,836,951May 24 06:46 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 22Buy3.7310,00037,3003,796,951May 23 07:15 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 21Buy3.8290,000344,0963,786,951May 22 07:18 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 18Buy4.04100,000403,7893,696,951May 21 06:24 AM
Fishel Robert ScottDirectorMay 14Buy4.791,8008,6224,055,728May 15 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 04Buy3.1426,00081,5403,596,951May 07 06:58 AM
Fishel Robert ScottDirectorMay 04Buy3.145,00015,7004,053,928May 07 06:57 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 03Buy3.0951,800159,9983,570,951May 04 06:57 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 02Buy3.1550,330158,6303,519,151May 03 06:02 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 01Buy3.0531,22295,2103,468,821May 02 06:28 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 30Buy3.0875,000231,1263,437,599May 01 06:36 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 26Buy3.0331,80096,4493,362,599Apr 27 07:20 AM